436
Views
25
CrossRef citations to date
0
Altmetric
Research Paper

Acidic mucopolysaccharide from holothuria leucospilota has antitumor effect by inhibiting angiogenesis and tumor cell invasion in vivo and in vitro

Pages 1489-1499 | Published online: 01 Aug 2009
 

Abstract

Acidic mucopolysaccharide from Holothuria Leucospilota(HS)may affect some steps in metastasis cascade. In vitro, HS inhibited the growth of B16F10 cells and proliferation of VEGF-induced HUVEC dose-dependently compared to the control, VEGF-induced capillary-like tube networks and the numbers of migratory and invasive cells were significantly inhibited by HS in a dose-dependent manner under the cytotoxic doses. Additionally, VEGF-induced vessel sprouting of rat aortic ring was also inhibited by HS. It also has been demonstrated that the invasive ability of B16F10 melanoma cells through the Matrigel-embedded Boyden chamber was suppressed by 0.5μM HS. The protein level secreted by B16F10 cells of MMP-2,-9 and VEGF were decreased by HS treatment. In vivo, a tumor growth inhibition study was carried out using mice bearing B16F10 cells model of metastasis, no matter experimental or spontaneous, showed that HS at 5.2, 11.6 and 26mg/kg (weight of mice) could markedly decreased the metastatic tumors in mouse lung in a dose-dependent manner. In CAM assay and Matrigel plug assay in vivo, HS (50μg/egg and 100μg/egg) inhibited new blood vessel formation on the growing chick chorioallantoic membrane, and HS (5.2 and 26mg/kg body weight) reduced the vessel density in Matrigel plugs implanted in mice. Taken together, these results demonstrate that HS has antimetastasic properties possibly via its antiangiogenesis induced by down regulation of VEGF and suppression of invasive ability of cancer cells mediated by down regulation of MMP-2, -9 and their activity.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.